Peter L. Duffy
Peter L. Duffy publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Coronary Interventions and Diagnostics, Antiplatelet Therapy and Cardiovascular Diseases and Acute Myocardial Infarction Research.
- World rank
- #970,238 of 7,710,434 ranked researchers
- Rank in United States
- #317,898 of 1,627,098
- Works
- 155
- Citations
- 4k
- Citations per work
- 25.7
What does Peter L. Duffy research?
Peter L. Duffy's work is mostly in Medicine (69%), Health Professions (4%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11272.2%
- Medicine10668.6%
- Health Professions63.6%
- Everything else3925.2%
- Social Sciences42.6%
- 1Cardiology and Cardiovascular Medicine32% of their works
- 2Surgery26% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Pulmonary and Respiratory Medicine4% of their works
- 5General Health Professions4% of their works
- 6Economics and Econometrics3% of their works
Research topics
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Peripheral Artery Disease Management
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
Which keywords describe Peter L. Duffy's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Atherosclerosis, Coronary Stents, Myocardial Revascularization, Guidelines, Aspirin, Clopidogrel and Myocardial Infarction.
- Antithrombotic Therapy
- Anticoagulant Therapy
- Angioplasty
- Cardiac Risk
- Coronary Artery Disease
- ST-Segment Elevation
- Myocardial Infarction
- Aspirin
- Myocardial Revascularization
- Atherosclerosis
- Percutaneous Coronary Intervention
- Coronary Stents
- Guidelines
- Clopidogrel
- Acute Coronary Syndromes
- Cardiac Imaging
- Risk Factors
- Perioperative
- Peripheral Arterial Disease
- Atrial Fibrillation
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Percutaneous Coronary Intervention1272 topics
- Atherosclerosis862 topics
- Coronary Stents751 topic
- Myocardial Revascularization751 topic
- Guidelines664 topics
- Aspirin521 topic
- Clopidogrel521 topic
- Myocardial Infarction482 topics
- Acute Coronary Syndromes291 topic
- ST-Segment Elevation291 topic
- Cardiac Imaging191 topic
- Coronary Artery Disease191 topic
- Risk Factors192 topics
- Cardiac Risk161 topic
- Perioperative161 topic
- Angioplasty111 topic
- Peripheral Arterial Disease111 topic
- Anticoagulant Therapy101 topic
- Atrial Fibrillation101 topic
- Antithrombotic Therapy81 topic
- Venous Thromboembolism81 topic
Where does Peter L. Duffy work?
Peter L. Duffy's main affiliation in the publication record is Cardiovascular Research Foundation, United States.
How many publications and citations does Peter L. Duffy have?
OpenAlex counts 155 works and 3,989 citations for Peter L. Duffy, an h-index of 29, ranking #970,238 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter L. Duffy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.